Ecolab Inc. (ECL) and International Flavors & Fragrances Inc. (IFF) occupy adjacent corners of the specialty chemicals and ingredients landscape, yet they appeal to very different investor theses. Ecolab is a water, hygiene, and infection-prevention leader increasingly positioned around high-growth data-center cooling and digital technology, while IFF is executing a multi-year portfolio reset centered on flavors, fragrances, and biosciences. This stock comparison is relevant for investors weighing a diversified, recurring-revenue growth compounder against a leveraged turnaround and divestiture story. Understanding their relative performance, market positioning, and catalysts can help traders and longer-term investors assess which risk-and-reward profile better fits the current environment.
Ecolab provides water treatment, cleaning, sanitation, and infection-prevention solutions to industrial, institutional, and food-and-beverage customers. In recent weeks, sentiment has been shaped by accelerating growth in its Global High-Tech segment, which serves microelectronics and data centers. Recent market activity followed the acquisitions of CoolIT Systems, a liquid-cooling provider, and Ovivo Electronics, deepening Ecolab's exposure to AI-driven data-center demand. Management has raised its 2026 adjusted earnings-per-share (EPS) outlook to a range of roughly $8.05 to $8.25, while reporting double-digit sales growth and firm pricing. That momentum has supported a multi-month share-price advance, though higher acquisition-related debt and financing costs have tempered some enthusiasm. The stock trades at a premium valuation, reflecting its recurring service model and expanding technology exposure.
International Flavors & Fragrances creates flavors, fragrances, food-ingredient, and bioscience solutions for consumer products, food and beverage, and health applications. Recent market activity has been driven by portfolio simplification: the company agreed to sell its Food Ingredients business to CVC Capital Partners for roughly $4.3 billion, expected to close by mid-2027, while retaining a minority stake. IFF has reported volume-led growth across its segments, its highest adjusted EBITDA margin in several years, and a sharp reduction in gross debt. The company has also authorized a multi-billion-dollar share repurchase program and received a credit-rating upgrade to BBB from S&P Global Ratings. These developments have fueled a strong year-to-date advance and improving sentiment, though divestiture timing and softer commodity fragrance demand remain watchpoints.
For investors who prefer a systematic approach to stock selection, Tickeron's Trending AI Robots page offers a curated view of automated trading strategies. Tickeron hosts hundreds of AI trading bots that collectively monitor thousands of tickers, but only the most suitable performers for current market conditions are featured in this section. The available bots span diverse trading styles, strategies, timeframes, performance metrics, and sets of tickers, giving users a range of tools to evaluate. Because market conditions shift, the featured bots are refreshed to reflect those that are currently aligning best with prevailing trends. Exploring the page can help traders compare how automated systems are reading the market and identify approaches that match their own analytical style.
The two companies differ fundamentally in business model and growth drivers. Ecolab benefits from recurring service contracts, pricing power, and a push into high-growth technology niches such as data-center liquid cooling and digital monitoring. IFF, by contrast, is a product- and innovation-led ingredients business whose near-term story hinges on divesting lower-margin assets and paying down debt. In terms of recent momentum, both stocks have performed well, but Ecolab's advance reflects organic sales growth and margin discipline, while IFF's reflects a re-rating tied to balance-sheet repair and portfolio focus. Risk profiles also diverge: Ecolab carries elevated leverage and integration risk from recent acquisitions, whereas IFF faces execution risk around its Food Ingredients sale and sensitivity to energy and logistics costs. Sector exposure differs too, with Ecolab tied to water and institutional markets and IFF to consumer, food, and bioscience end-markets.
Based on observable factors, Tickeron's AI would likely lean toward Ecolab for its more consistent trend structure, diversified growth engines, and clearly defined catalysts in data-center cooling and pricing. Ecolab's recurring revenue base and raised earnings outlook suggest steadier, more predictable momentum. IFF, while showing strong recent performance and improving fundamentals, remains more event-dependent, with its valuation and trajectory closely tied to the successful completion of the Food Ingredients divestiture. A probabilistic assessment therefore favors Ecolab for trend consistency and stability, while acknowledging that IFF's transformation could sustain its upward momentum if execution remains on track.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for ECL crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
ECL moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECL advanced for three days, in 171 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Aroon Indicator entered an Uptrend today. In 108 of 270 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 40%.
The 10-day RSI Indicator for ECL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In 21 of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at 44%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 68 cases where ECL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
ECL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.382) is normal, around the industry mean (2.284). P/E Ratio (40.091) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (2.525) is also within normal values, averaging (1.548). Dividend Yield (0.010) settles around the average of (0.039) among similar stocks. P/S Ratio (4.621) is also within normal values, averaging (48.960).
IFF moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 67%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IFF as a result. In 47 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.
The Moving Average Convergence Divergence Histogram (MACD) for IFF turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 30 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IFF's RSI Indicator exited the oversold zone, 18 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for IFF crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +4.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where IFF advanced for three days, in 175 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
IFF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 125 of 213 cases where IFF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. IFF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.508) is normal, around the industry mean (2.284). P/E Ratio (75.798) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (1.767) is also within normal values, averaging (1.548). Dividend Yield (0.019) settles around the average of (0.039) among similar stocks. P/S Ratio (2.004) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IFF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
ECL | IFF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 33 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 43 | 100 | |
SMR RATING 1..100 | 45 | 88 | |
PRICE GROWTH RATING 1..100 | 24 | 47 | |
P/E GROWTH RATING 1..100 | 34 | 3 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IFF's Valuation (80) in the Household Or Personal Care industry is in the same range as ECL (90) in the Chemicals Specialty industry. This means that IFF’s stock grew similarly to ECL’s over the last 12 months.
ECL's Profit vs Risk Rating (43) in the Chemicals Specialty industry is somewhat better than the same rating for IFF (100) in the Household Or Personal Care industry. This means that ECL’s stock grew somewhat faster than IFF’s over the last 12 months.
ECL's SMR Rating (45) in the Chemicals Specialty industry is somewhat better than the same rating for IFF (88) in the Household Or Personal Care industry. This means that ECL’s stock grew somewhat faster than IFF’s over the last 12 months.
ECL's Price Growth Rating (24) in the Chemicals Specialty industry is in the same range as IFF (47) in the Household Or Personal Care industry. This means that ECL’s stock grew similarly to IFF’s over the last 12 months.
IFF's P/E Growth Rating (3) in the Household Or Personal Care industry is in the same range as ECL (34) in the Chemicals Specialty industry. This means that IFF’s stock grew similarly to ECL’s over the last 12 months.
| ECL | IFF | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 44% | 1 day ago 60% |
| Stochastic ODDS (%) | 1 day ago 54% | 1 day ago 63% |
| Momentum ODDS (%) | N/A | 1 day ago 59% |
| MACD ODDS (%) | N/A | 1 day ago 56% |
| TrendWeek ODDS (%) | 1 day ago 51% | 1 day ago 59% |
| TrendMonth ODDS (%) | 1 day ago 49% | 1 day ago 59% |
| Advances ODDS (%) | 10 days ago 52% | 10 days ago 57% |
| Declines ODDS (%) | 6 days ago 52% | 1 day ago 59% |
| BollingerBands ODDS (%) | 1 day ago 43% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 40% | 1 day ago 59% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ECL’s FA Score shows that 1 FA rating(s) are green while IFF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ECL’s TA Score shows that 4 TA indicator(s) are bullish while IFF’s TA Score has 6 bullish TA indicator(s).
ECL (@Chemicals: Specialty) experienced а +0.44% price change this week, while IFF (@Chemicals: Specialty) price change was -9.77% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -3.13%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was -9.57%.
ECL is expected to report earnings on Feb 16, 2027.
IFF is expected to report earnings on Feb 10, 2027.
The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
A.I.dvisor indicates that over the last year, ECL has been closely correlated with SHW. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ECL jumps, then SHW could also see price increases.
A.I.dvisor indicates that over the last year, IFF has been loosely correlated with ECL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IFF jumps, then ECL could also see price increases.